The multiple sclerosis risk sharing scheme

BMJ (Online)

Volumn 340, Issue 7759, 2010, Pages 1255-

  Scolding, Neil ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER; MONOCLONAL ANTIBODY;

BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL NURSE SPECIALIST; CLINICAL PRACTICE; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; EDITORIAL; FINANCIAL MANAGEMENT; GOVERNMENT; HUMAN; INFLAMMATION; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; NATIONAL HEALTH ORGANIZATION; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RELAPSE; RISK MANAGEMENT; TISSUE REPAIR; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; DRUG COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERFERONS; MULTIPLE SCLEROSIS; PEPTIDES; RISK SHARING, FINANCIAL; TREATMENT OUTCOME;

EID: 77953701843     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c2882     Document Type: Editorial

References (8)

1. Ebers GC. Outcome measures were flawed [commentary]. BMJ 2010;340:c2693.[Free Full Text]
2. Compston A. Scheme has benefited patients [commentary]. BMJ 2010;340:c2707.[Free Full Text]
3. McCabe C, Chilcott J, Claxton K, Tappenden P, Cooper C, Roberts J, et al. Continuing the multiple sclerosis risk sharing scheme is unjustified. BMJ 2010;340:c1786.[Free Full Text]
4. Raftery J. Multiple sclerosis risk sharing scheme: a costly failure. BMJ 2010;340:c1672.[Free Full Text]
5. Degenhardt A, Ramagopalan SV, Scalfari A, Ebers GC. Clinical prognostic factors in multiple sclerosis: a natural history review. Nat Rev Neurol 2009;5:672-82.[CrossRef][Web of Science][Medline]
6. Coles AJ, Wing MG, Molyneux P, Paolillo A, Davie CM, Hale G, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999;46:296-304.[CrossRef][Web of Science][Medline] (Pubitemid 29416266)
7. Boggild M, Palace J, Barton P, Ben-Shlomo Y, Bregenzer T, Dobson C, et al. Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator. BMJ 2009;339:b4677.[Abstract/Free Full Text]
8. Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, Ffrench-Constant C, et al. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 2006;54:297-303.[CrossRef][Web of Science][Medline] (Pubitemid 44316234)